Elon Musk is still trying to buy Twitter – will he succeed and should you care?
Elon Musk has unveiled a $46.5bn financing package to fund his mooted buyout of Twitter. But why is he so keen to buy, and what does he really want with it?

It seems that Elon Musk is still serious about trying to take Twitter (NYSE: TWTR) private.
In the latest twist, the billionaire has unveiled a $46.5bn financing package to fund his buyout.
It’s not surprising he’s managed to find the money – the billionaire executive of Tesla (Nasdaq: TSLA) is currently the richest person in the world, according to the Bloomberg Billionaires Index, with a fortune of $260bn.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Musk has lined up $25.5bn in debt financing, including a margin loan of $12.5bn against his stake in Tesla, from his major banking partners. He is also looking to provide $21bn of equity for the deal himself.
A bit of financial gymnastics will allow the billionaire to put up this figure without too much pain. The margin loan is secured against 85% of his 17% stake in Tesla, which is worth around $170bn at current prices.
That limits the amount of stock Musk can sell to fund the deal. However, under Tesla’s controversial 2018 bonus scheme, the CEO has three opportunities to buy more than eight million shares (each time) in the electric vehicle manufacturer at a 90% discount. With the next tranche of the bonus scheme set to kick in soon, this could provide the extra funding he needs for the equity slice.
Elon Musk needs to convince Twitter to sell
However, finding the money to finance the bid – which is an interesting challenge – was never really the biggest problem for Musk. Convincing the company to give itself up was always going to be a bigger headache.
And it doesn’t look as if Twitter is going to bend to Musk's wishes any time soon.
Last week it launched a so-called “poison pill” defence against the bid, aimed at blocking him from building a stake of more than 15%. The structure will allow existing investors to buy more shares at a heavy discount if Musk or anyone else attempts to buy more than 15% of the company without the board‘s backing.
Tesla’s CEO already owns 9.2% of Twitter and has said he is exploring a tender offer to buy a bigger stake in the company. Such a move is usually considered a hostile act because it bypasses the board of directors, who are ultimately supposed to represent shareholders. And now it would trigger the poison-pill defence, diluting his stake, and increasing the cost of a potential buyout.
Interestingly, Twitter has yet to issue a formal response to the initial buyout offer, so there could be yet another twist in this tale.
Is there something else going on behind the scenes?
The bigger question is what does Musk really want with Twitter? He has claimed that the company is a platform for free speech around the world and he wants to defend this right. However, the enterprise does not fit well alongside his collection of other businesses, namely Tesla and SpaceX, and the group is struggling for direction.
Twitter is trying to boost revenues by getting advertisers to pay more for their brands to appear on users' timelines, but it is still losing money. It reported a net loss of $221m in 2021 on revenues of more than $5bn.
Some of Musk’s critics have speculated that he could be pursuing Twitter in order to divert attention from as-yet-to-be-seen problems. If this is the case, it’s an expensive way to distract the media, but for a billionaire who has a history of playing fast and loose with the rules – and one whose own Twitter stream is essentially an ongoing publicity stunt – it would not be out of character.
It might be best for investors to sit this one out, rather than trying to guess what’s in store for either side of this increasingly bitter battle.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Rupert is the former deputy digital editor of MoneyWeek. He's an active investor and has always been fascinated by the world of business and investing. His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.
Rupert has written for many UK and international publications including the Motley Fool, Gurufocus and ValueWalk, aimed at a range of readers; from the first timers to experienced high-net-worth individuals. Rupert has also founded and managed several businesses, including the New York-based hedge fund newsletter, Hidden Value Stocks. He has written over 20 ebooks and appeared as an expert commentator on the BBC World Service.
-
Cash in on the growth prospects of Europe's companies
Opinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
By Marcel Stotzel Published
-
Is the AI boom another dotcom bubble?
25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
By Dan McEvoy Published
-
The cybersecurity stocks to buy as the sector booms
Tips The consultancy McKinsey estimates that $150bn was spent on cybersecurity in 2021, and that number is only set to grow. Here are the stocks to buy to profit.
By Dr Matthew Partridge Published
-
Tech stocks have plunged this year, but is now the time to buy?
Tips Tech stocks have faced heavy selling pressure this year, although all of these firms have bright futures.
By Rupert Hargreaves Published
-
Why Big Tech’s move into medicine is a mistake
Opinion The big tech companies have long wanted a slice of the medical action, and now they are moving in. They are making a big mistake and will fae a huge backlash, says Matthew Lynn.
By Matthew Lynn Published
-
Just how powerful is artificial intelligence becoming?
Briefings An uncannily human response from an artificial intelligence program sparked a minor panic last month. But just how powerful are machines getting – and should we be worried?
By Simon Wilson Published
-
What to buy as the tech-stock bull market crashes
Cover Story The decade-long bull market in tech stocks has come to a rapid halt. Investors need to distinguish solid stocks from speculative ones rather than just buying the dip, says Matthew Partridge
By Dr Matthew Partridge Published
-
Tech stock crash – dotcom bust 2.0 is upon us
Opinion It’s carnage in the tech sector as the market crashes. But that spells opportunity for canny investors, says Matthew Lynn
By Matthew Lynn Published
-
Fang tech stocks: Meta and Netflix lose their bite
Analysis Investors treated the Fang tech stocks as almost identical, but two of them are much weaker than the rest, says Philip Pilkington.
By Philip Pilkington Published
-
Alphabet and Microsoft look like gems in the rubble of the tech sector
Analysis Tech stocks have fallen hard this, with the Nasdaq index down 22% since November. But both Alphabet and Microsoft are still both worth a look, says Rupert Hargreaves.
By Rupert Hargreaves Published